Indication

Colorectal cancer

Colorectal cancer is a malignant neoplasm originating from the epithelial lining of the large intestine, encompassing either the colon or the rectum. Read more about Colorectal cancer

17 drugs 17 manufacturers

Advertisement

Drugs that treat it

Common Colorectal cancer therapies.

Showing 1–9 of 17 drugs

FLUOROURACIL

5 FLUOROPYRIMIDINES·METASTATIC COLORECTAL CANCER·+4
APP/NOVAPLUS

FLUOROURACIL

5 FLUOROPYRIMIDINES·METASTATIC COLORECTAL CANCER·+4
APP/PREMIERPRO

FLUOROURACIL

5 FLUOROPYRIMIDINES·METASTATIC COLORECTAL CANCER·+4
BLUEPOINT LABOR

FLUOROURACIL

5 FLUOROPYRIMIDINES·METASTATIC COLORECTAL CANCER·+4
APP/FRESENIUS K
Filter & compare in the drug finder →Opens the drug finder with Colorectal cancer preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Colorectal cancer.

Colorectal cancer is a malignant neoplasm originating from the epithelial lining of the large intestine, encompassing either the colon or the rectum.

It predominantly develops in older adults, though it also occurs in younger populations, through the gradual malignant transformation of precancerous adenomatous or serrated polyps driven by progressive genetic and epigenetic alterations.

Pathologically, the vast majority of cases are adenocarcinomas that arise in the glandular epithelium of the intestinal mucosa.

Defining clinical features often include occult or overt gastrointestinal bleeding, persistent alterations in bowel habits, iron deficiency anemia, abdominal discomfort, and intestinal obstruction in advanced or metastatic stages.

Personalize your experience

Follow Colorectal cancer and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it